E. Sánchez

Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.

M. Piris, J. Suela, M. Sánchez-Beato, 2010, The American journal of pathology.

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.

M. Piris, E. Sánchez, J. L. Orradre, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

K. Turteltaub, E. Sánchez, D. Boocock, 2002, Carcinogenesis.

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

A. Sánchez-Aguilera, M. Piris, M. Sánchez-Beato, 2001, The American journal of pathology.

Crystal‐storing histiocytosis and immunocytoma associated with multifocal fibrosclerosis

M. Piris, E. Sánchez, E. Lloret, 1998, Histopathology.

Development of a Real-Time Reverse Transcription Polymerase Chain Reaction Assay for c-myc Expression That Allows the Identification of a Subset of c-myc+ Diffuse Large B-Cell Lymphoma

J. Cigudosa, M. Piris, M. Sánchez-Beato, 2003, Laboratory Investigation.

Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

J. Cigudosa, M. Vidal, M. Piris, 2006, Modern Pathology.

Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFκB transcription factors

Juan F. García, M. Fraga, M. Esteller, 2004, The Journal of pathology.

© 1999 Cancer Research Campaign Article no. bjoc.1999.0539 p27 KIP1 is abnormally expressed in Diffuse Large B-Cell

M. Piris, M. Sánchez-Beato, E. Sánchez, 2022 .

Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.

E. Campo, M. Piris, E. Sánchez, 1995, The American journal of surgical pathology.

p27KIP1 is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome

M. Piris, M. Sánchez-Beato, E. Sánchez, 1999 .